We are live on ! Find out more
TCM

Traynor Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 62.36%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.9%
AUM
$141M
AUM Growth
+$13.6M
Cap. Flow
+$8.04M
Cap. Flow %
5.69%
Top 10 Hldgs %
44.78%
Holding
141
New
13
Increased
69
Reduced
42
Closed
14

Sector Composition

Rank Sector Weight
1 Communication Services 10.18%
2 Technology 10.14%
3 Healthcare 8.29%
4 Consumer Discretionary 6.27%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORIG
126
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
$18K 0.01%
2
-7
-78% -$93.2K
BCS icon
127
Barclays
BCS
$95B
-26,945
Closed -$182K
CRF
128
Cornerstone Total Return Fund
CRF
$1.16B
-28,899
Closed -$470K
CRK icon
129
Comstock Resources
CRK
$3.88B
-8,000
Closed -$32K
F icon
130
Ford
F
$55B
-21,127
Closed -$261K
JBLU icon
131
JetBlue
JBLU
$2.34B
-10,642
Closed -$175K
KMB icon
132
Kimberly-Clark
KMB
$36.1B
-25,370
Closed -$206K
MOS icon
133
The Mosaic Company
MOS
$7.46B
-8,569
Closed -$218K
ORCL icon
134
Oracle
ORCL
$413B
-5,445
Closed -$219K
TMO icon
135
Thermo Fisher Scientific
TMO
$214B
-21,043
Closed -$1.28M
TNK icon
136
Teekay Tankers
TNK
$2.67B
-5,000
Closed
VTRS icon
137
Viatris
VTRS
$19B
-5,612
Closed -$239K
CS
138
DELISTED
Credit Suisse Group
CS
-10,800
Closed -$110K
SGYP
139
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
-12,175
Closed -$46K
PDLI
140
DELISTED
PDL BioPharma, Inc.
PDLI
-28,534
Closed -$88K
AIM
141
AIM ImmunoTech
AIM
$7.51M
0
-$3K

Similar funds

Traynor Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Traynor Capital Management held 141 positions worth $141M, up 11% from $128M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Traynor Capital Management deployed $8.04M of net new capital in Q3 2016, opening 13 new positions and adding to 69 existing holdings. Its largest new stake was Direxion Daily Small Cap Bull 3x ETF: 39,814 shares worth $1.48M.

By sector, the portfolio is most concentrated in Communication Services at 10% of assets, up from 9.1% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Novo Nordisk, an estimated $254K trimmed.

  • Traynor Capital Management's largest Q3 2016 buy was Direxion Daily Small Cap Bull 3x ETF: 39,814 shares worth $1.48M.
  • Traynor Capital Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2016, an estimated $868K increase.
  • Traynor Capital Management's biggest Q3 2016 reduction was Novo Nordisk, cutting an estimated $254K.
  • Traynor Capital Management fully exited Thermo Fisher Scientific in Q3 2016, selling an estimated $1.28M.
  • Traynor Capital Management's ten largest holdings make up 45% of its $141M portfolio in Q3 2016.
  • Traynor Capital Management opened 13 new positions and closed 14 in Q3 2016.
  • Traynor Capital Management's portfolio value rose 11% quarter-over-quarter to $141M.

Based on Traynor Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.